Company
Catheter Precision
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
3
510(k), De Novo and PMA
Device trials
2
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Catheter Precision, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Catheter Precision.
Latest FDA decisions
- VIVO (9002)510(k)
K261886 · Decided Oct 30, 2026 · 147 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
- VIVO510(k)
K200313 · Decided Sep 14, 2020 · 221 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
- VIVO510(k)
K183195 · Decided Jun 14, 2019 · 207 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- VIVO European Observational RegistryCompleted
NCT04990089 · 125 participants · Start Oct 21, 2021 · Primary completion Jun 28, 2024
Device: VIVO · For: Ventricular Arrythmia; Ventricular Tachycardia; Premature Ventricular Contraction
Sites: Dublin, Ireland; Ascoli Piceno, Italy; Groningen, Netherlands · 8 sites in all
- VIVO™ Accuracy StudyCompleted
NCT03340142 · 45 participants · Start Jan 29, 2018 · Primary completion Sep 4, 2018
Device: VIVO™ · For: Premature Ventricular Contraction; Ventricular Tachycardia
Sites: Iowa City, Iowa; Baltimore, Maryland; Charleston, South Carolina
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.